XML 33 R16.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 10 - Options and Warrants to Purchase Common Stock
12 Months Ended
Dec. 31, 2015
Notes to Financial Statements  
Options And Warrants To Purchase Common Stock [Text Block]
NOTE
10
OPTIONS
AND
WARRANTS
TO
PURCHASE
COMMON
STOCK
 
Derivative
Instruments
-
Warrants
The Company issued 5,000,000 warrants (“Samlyn Warrants”) in connection with the December 22, 2011 private placement of 10,000,000 shares of common stock. The strike price of these warrants was $2.00 per share at the date of grant. These warrants were not issued with the intent of effectively hedging any future cash flow, fair value of any asset, liability or any net investment in a foreign operation. In addition to the customary anti-dilution provisions the notes contain a down-round provision whereby the exercise price would be adjusted downward in the event that additional shares of the Company's common stock or securities exercisable, convertible or exchangeable for the Company's common stock were issued at a price less than the exercise price. Therefore, the fair value of these warrants (based on observable inputs) was recorded as a liability in the balance sheet until they were canceled.
 
During the first quarter of 2013, the Company issued 3,756,757 shares of its common stock for gross proceeds of $5,560,000, which triggered a down-round adjustment of $0.03 from $2.00 to $1.97 in the strike price of the Samlyn Warrants at that time. As discussed in Note 8, during August 2013, the Company issued $10,500,000 of 10% mandatorily convertible Series 2023 Notes in a private placement, which triggered a down-round adjustment of $0.04 from $1.97 to $1.93 in the strike price of the Samlyn Warrants. On November 3, 2014, the Company cancelled the warrant arrangement, resulting in a $120,000 credit to equity.
 
During 2014 and 2013, the Company recorded other income of $830,000 and $995,000, respectively, resulting from the changes in the fair value of the warrant liability, mainly due to a lower stock price and a change in the volatility utilized by the Company.
 
Outstanding
Stock
Warrants
A summary of the status of the warrants outstanding and exercisable at December 31, 2015 is presented below:
 
       
Warrants Outstanding and Exercisable
 
Exercise Price
   
Number
Outstanding
   
Weighted Average
Remaining
Contractual Life (years)
   
Weighted
Average
Exercise Price
 
$ 0.78       213,402       0.09     $ 0.78  
$ 1.15       461,340       5.33     $ 1.15  
$ 2.00       54,367       0.59     $ 2.00  
          729,109       3.44     $ 1.11  
 
During 2015, warrants to acquire 443,821 shares of common stock expired. No warrants were issued during 2013, 2014 and 2015.
 
Outstanding
Stock
Options
On November 20, 2012, the shareholders of the Company approved the adoption of the Applied Minerals, Inc. 2012 Long-Term Incentive Plan (“LTIP”) and the Short-Term Incentive Plan (“STIP”) and the performance criteria used in setting performance goals for awards intended to be performance-based. Under the LTIP, 8,900,000 shares are authorized for issuance. The STIP does not refer to a particular number of shares under the LTIP, but would use the shares authorized in the LTIP for issuance under the STIP. The CEO, the CFO, and named executive officers, and directors, among others are eligible to participate in the LTIP and STIP. Prior to the adoption of the LTIP and STIP, stock options were granted under individual arrangements between the Company and the grantees, and approved by the Board of Directors.
 
The fair value of each of the Company's stock option awards is estimated on the date of grant using the Black-Scholes option-pricing model that uses the assumptions noted in the table below. Expected volatility is based on an average of historical volatility of the Company's common stock. The risk-free interest rate for periods within the contractual life of the stock option award is based on the yield curve of a zero-coupon U.S. Treasury Bond on the date the award is granted with a maturity equal to the expected term of the award.
 
The significant assumptions relating to the valuation of the Company's options issued for 2015 and 2014 were as follows on a weighted average basis:
 
   
2015
   
2014
 
Dividend Yield
    0 %     0 %
Expected Life (in years)
    7.00       5.5  
Expected Volatility
    72.9 %     56.1 %
Risk Free Interest Rate
    2.00 %     1.79 %
 
A summary of the status and changes of the options granted under stock option plans and other agreements for 2015 and 2014 is as follows:
 
   
December 31, 2015
   
December 31, 2014
 
           
Weighted
           
Weighted
 
           
Average
           
Average
 
   
Shares
   
Exercise Price
   
Shares
   
Exercise Price
 
                                 
Outstanding at beginning of period
    17,053,116     $ 1.02       15,878,116     $ 1.03  
Issued
    1,138,356       0.63       1,175,000       0.84  
Exercised
    --       --       --       --  
Forfeited
    (235,000 )   $ 0.77       --       --  
Outstanding at end of period
    17,956,472     $ 1.00       17,053,116     $ 1.02  
 
During the year ended December 31, 2015, the Company granted 1,138,356 options to purchase the Company’s common stock with a weighted average exercise price of $0.63. Of the 1,138,356 options granted, the options vest as follows:
 
   
Vesting Information
Shares
 
Frequency
 
Begin Date
 
End Date
200,000  
Immediately
 
2/12/2015
 
2/12/2015
38,356  
Immediately
 
4/15/2015
 
4/15/2015
100,000  
Monthly
 
4/7/2015
 
4/7/2016
100,000  
Monthly
 
9/16/2015
 
9/16/2016
200,000  
Annually
 
2/5/2015
 
2/5/2018
350,000  
Annually
 
6/1/2015
 
6/1/2018
150,000  
Annually
 
11/10/2015
 
11/10/2018
 
A summary of the status of the options outstanding at December 31, 2015 is presented below:
 
Options Outstanding
   
Options Exercisable
 
                             
                             
      Weighted                      
      Average    
Weighted
           
Weighted
 
     
Remaining
   
Average
           
Average
 
 
   
Contractual
   
Exercise
   
Number
   
Exercise
 
Number Outstanding
   
Life (years)
   
Price
   
Exercisable
   
Price
 
                                   
100,000       4.72     $ 0.22       25,002     $ 0.22  
150,000       4.87     $ 0.50       -0-     $ N/A  
200,000       9.13     $ 0.66       200,000     $ 0.66  
150,000       9.11     $ 0.68       -0-     $ N/A  
7,233,277       2.99     $ 0.70       7,233,277     $ 0.70  
488,356       9.38     $ 0.73       94,178     $ 0.73  
3,405,134       5.69     $ 0.83       3,405,134     $ 0.83  
975,000       8.45     $ 0.84       691,667     $ 0.84  
300,000       7.64     $ 1.10       200,000     $ 1.10  
300,000       7.48     $ 1.15       233,333     $ 1.15  
100,000       2.09     $ 1.24       100,000     $ 1.24  
115,000       5.24     $ 1.35       115,000     $ 1.35  
125,000       2.09     $ 1.45       125,000     $ 1.45  
330,000       5.95     $ 1.55       330,000     $ 1.55  
7,645       2.09     $ 1.58       7,645     $ 1.58  
3,077,060       6.89     $ 1.66       3,077,060     $ 1.66  
900,000       5.64     $ 1.90       900,000     $ 1.90  
17,956,472       5.12     $ 1.00       16,737,296     $ 1.01  
 
Compensation expense of $397,417, $865,716, and $4,707,381 has been recognized for the vested options for the years ended December 31, 2015, 2014 and 2013, respectively. The aggregate intrinsic value of the outstanding options at December 31, 2015 was $6,500. At December 31, 2015, $354,284 of unamortized compensation expense for unvested options will be recognized over the next 5.12 years on a weighted average basis.